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Abstract Endonuclease III of Escherichia coli is normally
involved in the repair of oxidative DNA damage. Here, we have
investigated a possible role of EndoIII in the repair of alkylation
damage because of its structural similarity to the alkylation
repair enzyme 3-methyladenine DNA glycosylase II. It was
found that overproduction of EndoIII partially relieved the
alkylation sensitivity of alkA mutant cells. Site-directed
mutagenesis to make the active site of EndoIII more similar to
AlkA (K120W) had an adverse effect on the complementation
and the mutant protein apparently inhibited repair by competing
for the substrate without base release. These results suggest that
EndoIII might replace AlkA in some aspect of alkylation repair,
although high expression levels are needed to produce this
effect. ß 2001 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
DNA glycosylases catalyse the ¢rst step of the base excision
repair pathway by hydrolysing the N-glycosylic bond between
the modi¢ed base and the sugar moiety of nucleotides in the
DNA [1]. DNA glycosylases can be classi¢ed into two sepa-
rate groups based on the presence or absence of an associated
apurinic/apyrimidinic (AP)-lyase activity. In Escherichia coli,
endonuclease III (EndoIII) represents a bifunctional enzyme
with combined DNA glycosylase/AP-lyase activities, whereas
the alkylation DNA glycosylase AlkA is monofunctional
without any associated AP-lyase activity. During the AP-lyase
reaction, the sugar ring of the damaged nucleotide is con-
verted to an unsaturated aldehyde leaving a strand break on
the 3P-side of the remaining sugar-phosphate residue.
Typical substrates for AlkA are 3-methyladenine and
7-methylguanine, both of which are major lesions induced in
DNA by simple methylating agents [2]. Bacterial mutants car-
rying alkA1 are moderately sensitive to alkylating agents [3].
E. coli also possesses a second 3-methyladenine DNA glyco-
sylase encoded by the tag gene. The double mutant alkA1 tag
lacking both of these enzymes is extremely sensitive to alkyl-
ation exposure, emphasising the importance of this type of
enzyme for repair of alkylation damage.
EndoIII recognises ring-saturated pyrimidines, thymine gly-
cols, cytosine hydrates and rearranged pyrimidines such as
urea and hydantoins in the DNA [4]. These lesions are in-
duced by reactive oxygen species and are potentially cytotoxic.
However, E. coli mutants lacking EndoIII (nth) are not hyper-
sensitive to oxidising agents like H2O2 or Q-radiation [5]. The
lack of sensitivity can be explained by the presence of a back-
up enzyme, referred to as endonuclease VIII (EndoVIII), with
enzymatic properties similar to EndoIII [6,7]. However, En-
doIII has nevertheless been shown to possess strong activities
for removal of the major premutagenic pyrimidine lesions
such as uracil glycol, 5-hydroxycytosine and 5-hydroxyuracil,
and nth mutants exhibit increased spontaneous mutation fre-
quencies [8^10].
The three-dimensional structures of both EndoIII and
AlkA have been determined [11^14], and it appears that these
enzymes have an overall structural similarity except for the
N-terminal part of AlkA. In both cases, the hydrolysis of the
N-glycosylic bond seems to require £ip out of the base in-
volved. It is proposed that the base is stacked in the active
site that is formed between two K-helical domains present in
both AlkA and EndoIII. The helix-hairpin-helix (HhH) motif,
known from many proteins involved in DNA repair and re-
combination, is similarly positioned in both proteins, at the
entrance of the active site cleft. In spite of apparent di¡erences
in speci¢city, the mechanism for N-glycolytic cleavage appears
to be similar for AlkA and EndoIII. Hydrolysis of the
N-glycosylic bond proceeds by a nucleophilic attack of the
anomeric sugar carbon. EndoIII is assumed to use lysine at
position 120 as a nucleophile, whereas AlkA possibly uses a
water molecule [12,13,15]. Conserved aspartate residues in
EndoIII and AlkA (D138 and D238, respectively) are essential
for enzyme activity and presumably serve to activate the nu-
cleophiles.
The aim of the present study was to investigate a possible
role for EndoIII in DNA repair of alkylation damage. En-
doIII was overexpressed in alkylation repair defective mutants
and the active site of EndoIII was altered to make it more
similar to AlkA. The results support a minor role for EndoIII
in repair of some type of alkylation damage normally e¡ected
by AlkA.
2. Materials and methods
2.1. Bacterial strains
The strains used were AB1157 (wild-type), BK2118 (tag alkA1)
(from our own collection), MS23 (alkA1), BW415 (vnth), BK3002
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(alkA1 nth : :kan) and BK3035 (alkA1 nth umuDC). The BW415 and
BW372 strains were kindly provided by B. Weiss, strain GW8024
(originally constructed by R. Woodgate) was kindly provided by G.
Walker. Strain BK3002 (alkA1 nth) was constructed by bacteriophage
T4 transduction [16] of MS23 with phage lysates prepared from
BW372 (nth : :kan). The BK3035 (alkA1 nth umuDC) strain was con-
structed in a similar manner by transducing BK3002 with phage lysate
from strain GW8023 (umuDC : :ten5). The nth mutation of BK3002
was veri¢ed by PCR and umuDC mutation in strain BK3035 was
veri¢ed by its loss of mutability to UV light.
2.2. Expression plasmids, site-directed mutagenesis
The DNA fragment encoding nth was ampli¢ed from W3110 chro-
mosomal DNA by PCR subsequently cloned into the NcoI/HindIII
restriction sites of pKK233-2 (Pharmacia) for use in cell survival
studies. EndoIII protein was puri¢ed using an expression clone ob-
tained from Richard Cunningham. Site-directed mutagenesis was per-
formed by the Quick-Change method (Stratagene), using the two
complementary oligonucleotides: (only coding sequence shown) 5P-
CTGCCCGGCGTAGGTCGTTGGACAGCCAACGTC-3P. The mu-
tation was veri¢ed by DNA sequencing.
2.3. Cell survival measurements
Methylmethanesulphonate (MMS) sensitivity was monitored during
exponential growth (OD600nm = 1) by making appropriate cell dilu-
tions in ice-cold M9 bu¡er and plating on LB agar containing di¡er-
ent concentrations of MMS as indicated. For pKK233-2 constructs,
1 mM IPTG was added at a cell density of 0.3 (OD600nm) and was also
included in the agar plates.
2.4. Mutagenesis
Overnight cultures were diluted 1:20 in fresh medium (LB) and
allowed to grow to an OD600nmV0.7^1 prior to the addition of
MMS (5 mM). After 30 min exposure at 37‡C, the cell suspension
was diluted 1:50 in LB and incubated with shaking at 37‡C for 8 h.
Samples were plated on LB agar to determine the number of viable
cells and on rifampicin-containing plates (100 Wg/ml) to determine the
number of MMS-induced rifampicin resistant mutants (RifR). For
mutation frequency determinations following exposure to H2O2, ex-
ponentially growing cells were pelleted, washed and resuspended in
M9 bu¡er and subsequently left on ice for 15 min prior to incubation
with 5 mM H2O2 for 30 min at 37‡C.
2.5. EndoIII protein puri¢cation
The EndoIII construct and strain (BL21 de3) for expression were
kindly provided by Richard Cunningham. EndoIII and the K120W
mutant protein were puri¢ed using a modi¢ed procedure from that
described by Asahara et al. [17]. Brie£y, the polyethyleneimine super-
natant was dialysed against 0.1 M K2HPO4 pH 6.6, 10 mM L-mer-
captoethanol, 20% glycerol (bu¡er A) and loaded onto Sephadex CM
column and eluted batchwise with 0.5 and 1.0 M NaCl in bu¡er A.
The 0.5 M eluant was dialysed against bu¡er A and loaded on a
Resource S column (FPLC, Pharmacia). The EndoIII and the
K120W protein eluted between 0.2 and 0.23 M NaCl. The most con-
centrated fractions were puri¢ed further on a Superdex 75 column
(SMART; Pharmacia).
2.6. 5-Hydroxycytosine substrate preparation and activity assay
Duplex oligonucleotide containing one 5-hydroxycytosine (5OHC)
at a de¢ned position 5P-gctcatgcgcag-5OHC-ggaaagggagg-3P was pre-
pared and used in assays as described previously [18].
3. Results
3.1. Overexpression of EndoIII confers increased MMS
resistance of alkA mutants
Possible EndoIII alkylation repair activity was analysed by
overproducing EndoIII in bacterial mutants defective in the
alkyl-DNA glycosylase functions AlkA and Tag. Overexpres-
sion of EndoIII signi¢cantly increased the MMS survival of
alkA1 mutants indicating that some alkylation repair activity
could be an inherent property of EndoIII. The complementa-
tion e¡ect was observed both in the tag alkA1 double mutant
as well as in the alkA1 single mutant strain (Fig. 1A and B).
3.2. Characterisation of an alkA1 nth double mutant strain
In view of the possible role of EndoIII in alkylation repair,
we constructed a double mutant carrying both alkA1 and nth
mutations (BK3002) and tested for alkylation survival. How-
ever, introduction of nth in the alkA1 mutant did not render
the cells more sensitive to MMS (Fig. 1C). Also the single nth
mutant was found to be wild-type resistant to MMS (data not
shown). It is possible that EndoIII will recognise some le-
sion(s) induced by MMS, but with low a⁄nity such that
only overexpression of EndoIII may have a signi¢cant e¡ect
on survival.
We also measured the mutation frequencies in single and
double mutant cells exposed to MMS and H2O2 (Fig. 2). A
de¢ciency of AlkA caused an increase in the mutation fre-
quency induced by MMS (Fig. 2A), similarly as has previ-
ously been observed for the alkylating agent N-methyl-NP-ni-
tro-N-nitrosoguanidine [19]. H2O2 was found to induce
mutations more frequently in nth strains than in wild-type
cells. Hence, H2O2 was chosen as a mutagenic agent to eval-
uate possible substrate overlap between AlkA and EndoIII.
H2O2-induced mutations are formed more frequently in both
BK3002 (alkA1 nth) and BW415 (nth) than in MS23 (alkA1)
Fig. 1. MMS survival of BK2118 (tag alkA1) (A) and MS23 (alkA1) (B) cells transformed with pKK233-2 (a), nth (E) or nth(K120W) (O).
Survival responses of untransformed MS23 (alkA1) (E) and BK3002 (alkA1 nth) (O) to MMS are shown in C. Each point represents the aver-
age of two measurements obtained from two to three independent experiments. Error bars include the full range of the data point variation.
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or wild-type cells (Fig. 2B). The spontaneously formed muta-
tion rates were from 2.5 þ 1 (lowest; AB1157) to 7 þ 4 (high-
est; BK3002) RifR mutants per 108 survival cells, based on the
same number of experiments. The UmuDC errorprone bypass
function was inactivated in the alkA1 and nth strains to fur-
ther evaluate the nature of the formed mutations. Most of the
mutations induced by MMS in alkA1 strains were umuDC
dependent, consistent with methylated adenines representing
blocks to DNA replication. Also, the strain BK3035 (alkA1
nth umuDC) is slightly more sensitive to MMS exposure than
BK3002 (alkA1 nth) (data not shown). In contrast, the muta-
tions induced by H2O2 in the nth background were indepen-
dent of umuDC, indicating that the induced damage is directly
premutagenic rather than an obstacle to DNA replication.
These results are consistent with the previous ¢ndings that
AlkA is important in protecting the cell against the lethal
damages by alkylating agents, whereas the speci¢c role of
EndoIII appears to be attributed to protect the cell against
the mutagenic e¡ect of oxidative stress.
3.3. Generation of mutant EndoIII K120W protein with
similarity to AlkA
A lysine residue is present at the C-terminal side of the
helix-hairpin-helix motif in many di¡erent DNA glycosylases,
however, all proteins of the AlkA type have a tryptophan at
this position [1,20]. K120 in EndoIII was changed to trypto-
phan to make EndoIII more similar to AlkA. The K120W
mutant protein was expressed in alkA1 and tag alkA1 mutant
cells, and the cells were plated on agar plates containing
MMS. Surprisingly, it was found that the K120W mutant
protein made the alkA1 mutants even more sensitive to
MMS (Fig. 1A and B). The mutant protein was also expressed
in wild-type cells, with no e¡ect on the MMS sensitivity (data
not shown). However, overexpression of K120W markedly
diminished the colony size of wild-type cells exposed to
MMS (Table 1) consistent with some e¡ects of K120W on
the growth rate during MMS exposure. One interpretation
of these results might be that K120W interferes with the repair
of MMS-induced DNA damage in the absence of AlkA.
When present, AlkA seems to counteract the detrimental ef-
fects of K120W with respect to colony forming ability.
3.4. Characterisation of the EndoIII K120W mutant protein
The K120W mutant protein and EndoIII were puri¢ed to
near homogeneity (s 99% pure), and tested for their ability to
release alkylated base residues from 3H-methyl nitrosourea-
treated DNA. However, neither EndoIII nor K120W were
found to excise methyl lesions to any signi¢cant extent (data
not shown). Hence, the complementing e¡ect of EndoIII
in alkA1 mutants cannot readily be ascribed to excision of
3-methyladenine or 7-methylguanine.
Possible enzymatic activity of K120W protein was analysed
by its ability to cleave an oligonucleotide containing 5-hy-
droxycytosine. As shown in Fig. 3A, lanes 1^3, wild-type En-
Fig. 2. Induced mutation frequency in di¡erent strains exposed to
MMS (A) or H2O2 (B). Strains used were AB1157 (wild-type),
MS23 (alkA1), BW415 (nth), BK3002 (alkA1 nth) and BK3035
(alkA1 nth umuDC). Mutation rates were calculated from three inde-
pendent experiments in which 10 separate cultures were indepen-
dently exposed and plated. Error bars indicate standard deviation.
Table 1
Average colony diameter (mm) of AB1157 transformants plated on
LB agar containing MMS
MMS (mM) pKK233-2 Nth nth(K120W)
0 2.6 þ 0.1 2.4 þ 0.2 2.4 þ 0.1
4 1.3 þ 0.2 1.9 þ 0.2 0.92 þ 0.08
Colony diameter was measured after 20 h incubation at 37‡C. All
colonies on the same plate were uniformly sized. The values repre-
sent the averages of sizes determined from ¢ve colonies and their
standard deviations. No killing e¡ect was observed at 4 mM MMS
for AB1157.
Fig. 3. Interactions with 5-hydroxycytosine-containing DNA duplex
by EndoIII proteins. Incision (A) and binding (B) assays were car-
ried out with 100 pM of 32P-endlabelled duplex DNA in reaction
bu¡er. Incision assays were performed for 30 min at 37‡C with: no
enzyme (lane 1), 4 nM EndoIII protein (lane 2), 4 nM K120W pro-
tein (lane 3) and 40 pM EndoIII (lanes 4^6). In lanes 4, 5 and 6
the substrate was preincubated with 0, 0.04 and 4 nM of K120W
protein, respectively. In the binding assays, the reaction mixture was
incubated on ice for 15 min as follows: lane 1, no enzyme; lanes 2
and 3, 40 nM EndoIII; lanes 4 and 5, 40 nM K120W. In lanes 3
and 5, 100 nM of non-modi¢ed competitor DNA duplex was
added.
FEBS 24605 19-2-01
L. Eide et al./FEBS Letters 491 (2001) 59^62 61
doIII protein e⁄ciently cleaved the oligonucleotide, whereas
the K120W mutant protein did not produce any nicking ac-
tivity. By electromobility shift assays, we could demonstrate a
stable binding to 5-hydroxycytosine-containing DNA for
K120W but not for EndoIII (Fig. 3B). A complex formed
between damaged DNA and K120W could prevent excision
by the endogenous repair enzymes. As shown in Fig. 3A, lanes
4^6, preincubation of the 5-hydroxycytosine-containing DNA
with the K120W mutation protein reduced the extent of nick-
ing produced by EndoIII. Hence, the negative e¡ects of
K120W could be ascribed to repair inhibition by binding
without base release, preventing access by the active DNA
glycosylases.
4. Discussion
The potential role of EndoIII in alkylation repair was in-
vestigated. It appears that EndoIII by itself is capable of
partially suppressing the MMS sensitive phenotype of the
tag alkA1 and alkA1 mutants. This could imply that EndoIII
is capable of removing some alkylated bases with low a⁄nity,
or alternatively that EndoIII is responsible for repair of some
other type of lesion induced by exposure to MMS. A major
methylation product, 7-methylguanine, spontaneously con-
verts to formamidopyrimidine, which is recently shown to
be repaired by EndoIII [21,22]. It has also been found that
overexpression of EndoIII in yeast defective in the AP-endo-
nuclease APN1, reduces sensitivity to MMS [23]. The stimu-
latory e¡ect of EndoIII expression was ascribed to the AP-
lyase activity of EndoIII. It is possible that the 3P-incised AP-
site is processed more e⁄ciently and therefore is less toxic to
the cells than 5P-incised AP-sites.
When K120 was changed to W, to make EndoIII more sim-
ilar to AlkA, it was observed that the mutant EndoIII actually
interfered with the repair catalysed by AlkA in vivo as judged
from the reduced growth rate observed during MMS exposure
in wild-type bacteria (Table 1). Moreover, the alkA1 mutants
became even more MMS sensitive upon expression of K120W
(Fig. 1). The in vitro data show that the K120W protein
interacts with damaged DNA and prevents repair by EndoIII
(Fig. 3). Since the alkA1 nth double mutant was as sensitive to
MMS exposure as the alkA1 single mutant, the negative e¡ect
of K120W expression in MMS-exposed cells cannot be as-
cribed simply to the inactivation of the EndoIII function.
The role of the conserved tryptophan in the HhH motif for
alkylation repair has been proposed to involve stacking with
Z-electrobond-containing bases [13]. Hence, K120W may in-
terfere with innocuous alkylated bases like 7-methylguanine
and accentuate the damaging e¡ects of such lesions.
Recently, EndoIII homologues from Thermotoga maritima
and Aquifex aeolicus have been characterised and shown to
have 3-methyladenine DNA glycosylase activities [24]. This
suggests that changes of a limited number of residues in pro-
teins with a similar sca¡old can signi¢cantly alter the sub-
strate speci¢city. The residue in the T. maritima enzyme cor-
responding to K120 in EndoIII is a glutamate residue and the
enzyme was found to be monofunctional without any associ-
ated AP-lyase activity similarly as is the case for all other
alkylation repair DNA glycosylases. Engineering of EndoIII
to introduce a glutamate residue rather than a tryptophan at
position 120 might possibly have produced an enzyme with
enhanced activity for alkylation repair.
The damaging reactions of MMS are not fully understood.
Apart from methylating DNA, MMS also induces AP-sites
and strand breaks [25,26]. Moreover, cell exposure to MMS
may result in depletion of the glutathione levels, which in turn
increases oxidative stress [27]. Consequently, cellular sensitiv-
ity to MMS might to some extent be ascribed to e¡ects other
than alkylation, such as for instance oxidative stress for which
overproduction of EndoIII could be bene¢cial.
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